Buhisan, May Ann .

HRN: 04-00-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
AMPICILLIN 1GM (VIAL)
06/26/2024
06/28/2024
IV
2gm
Q6
Prom
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: